Ovarian Cancer Archives - Page 20 of 21 - Cancer Therapy Advisor

Ovarian Cancer

In Relapsed Ovarian Cancer, Topotecan + Carboplatin Failed to Improve PFS, OS

Topotecan plus carboplatin failed to improve progression-free survival (PFS) or overall survival (OS) compared with standard therapy (paclitaxel/carboplatin, gemcitabine/carboplatin, or carboplatin/pegylated doxorubicin) in patients with platinum-sensitive relapsed ovarian cancer, according to results of the randomized phase 3 HECTOR study presented at the 2012 American Society of Clinical Oncology Annual Meeting.

Next post in Gynecologic Cancer